Since the clinical manifestations and imaging results of ureteral SCNEC are not specific to other types of ureteral tumors, pathological detection of neuroendocrine markers, including the recommended Syn and CgA and CD56, remains an important method for diagnosing ureteral SCNEC (7). Here, NCAM1 is linked to ureter neoplasm.